Credit Suisse Downgrades Spectrum Pharmaceuticals (SPPI) to Underperform

Credit Suisse downgraded Spectrum Pharmaceuticals (NASDAQ: SPPI) from Neutral to Underperform.

For an analyst ratings summary and ratings history on Spectrum Pharmaceuticals click here. For more ratings news on Spectrum Pharmaceuticals click here. Shares of Spectrum Pharmaceuticals closed at $8.01 yesterday, with a 52 week range of $6.92-$17.48.

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW *NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here begin ad tag (tile=12) -- End ad tag --

Sign Up

Get the InvestingChannel
Free e-Letter Today

Learn More

Independent market opinion, analysis and ideas - delivered every business day

Premium market opinions, analysis, and ideas - delivered every business day

Editor's Picks